Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Fulgent Genetics Q2 Adjusted EPS $(0.08) Beats $(0.33) Estimate, Sales $67.85M Beat $62.68M Estimate

Author: Benzinga Newsdesk | August 04, 2023 07:01am
Fulgent Genetics (NASDAQ:FLGT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.33) by 75.76 percent. This is a 110.26 percent decrease over earnings of $0.78 per share from the same period last year. The company reported quarterly sales of $67.85 million which beat the analyst consensus estimate of $62.68 million by 8.25 percent. This is a 45.87 percent decrease over sales of $125.34 million the same period last year.

Posted In: FLGT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist